International Society of Pharmacometrics

Update: ISoP is focused on providing maximum value to all members of its global community. As we move forward, we are evaluating our programs and offerings using member feedback and data to make informed decisions for the Society. As part of this process, ISoP has decided to discontinue the alliance with JPKPD. We extend our deepest gratitude to JPKPD for their invaluable contributions and collaboration over the years, which have significantly enriched the field of pharmacometrics and systems pharmacology. This decision reflects ISoP’s ongoing efforts to adapt and align with the evolving needs of our members, ensuring the continued growth and innovation of our Society. We remain committed to fostering excellence and progress in our shared scientific community, and we wish JPKPD continued success in their endeavors. As ISoP looks to the future, we are excited about new opportunities to support our members and expand the impact of our collective work on a global scale. Together, we will continue to shape the future of pharmacometrics and beyond. #Isop #pharmacometrics #JPKPD

We are now accepting early nominations for ISoP’s prestigious awards! Do you know someone deserving of recognition? Nominate them today and we’ll reach out once our formal call opens in 2025. Awards include: ?? Lewis B. Sheiner Lecturer Award ?? ISoP Innovation Award ?? ISoP Leadership Award ?? ISoP Outstanding Research Manuscript Award ?? ISoP Emerging Scientist Award ?? ISoP Unsung Hero Award Submit your nomination here: https://buff.ly/4hS0u7H #ISoP #Pharmacometrics

?? With nearly 1,000 members from over 90 countries, ISoP is where the global Pharmacometrics community comes together to advance science, collaboration, and innovation. ?? Aligned with our mission, we sponsor local scientific meetings and support global partnerships to make a lasting impact in Pharmacometrics. On Giving Tuesday, December 3, 2024, join us in our mission to bring the Pharmacometrics world together and make a global impact through collaboration and innovation by making a donation to our Global Communities Program. ? Support Pharmacometrics Meetings Worldwide ?? Connect Communities Across the Globe ?? Bring ISoP to Local Events Together, we can achieve more! ?? Make a difference on Giving Tuesday – Donate to the Global Communities Program! https://buff.ly/3YZSjNK #Pharmacometrics #ISoP

Join us for the next webinar in the MIDD Webinar Series on November 20th! ?? Session Title: Lasting Injectables, Shorter Path to Approval ?? Wednesday, November 20th, 12 noon ET ???? Presenter: Emma Hughes Learn more about the speaker and register now: https://buff.ly/4hDRmmN Join ISoP to attend this webinar and access all MIDD Webinar Series Recordings: https://buff.ly/48t2te1 The MIDD Webinar Series is a series of webinars focused on shaping the future of drug development and regulatory decision-making.

?? That's a wrap! ACoP2024 has officially come to a close. A huge thank you to everyone who made this incredible event possible, especially Wei Gao, our amazing Conference Chair. ?? Your hard work and dedication made it all happen! We can't wait to see you all next year at ACoP 2025! ?? #ACoP2024 #ISoP #Pharmacometrics

This year, we received over 450 abstract submissions for the poster sessions, highlighting the incredible diversity of research in the field! Presenters took center stage, sharing their findings with fellow attendees. Here's a peek at the vibrant poster hall, brimming with innovative scientific work from researchers around the world! ??? #ACoP2024 #ISoP #Pharmacometrics

Following the Keynote session, Wei Gao moderated Charting New Frontiers: CDER's Quantitative Medicine Center of Excellence. Rajanikanth Madabushi and Robert Lionberger of the FDA joined ISoP Board Member Hao Zhu and Peter Stein from the U.S. Food and Drug Administration. #ACoP2024 #ISoP #Pharmacometrics

?? Kicking off Tuesday morning at #ACoP2024 with an insightful keynote from Peter Stein, MD. He shared on how decision making in drug development is facilitated by quantitative clinical pharmacology/pharmacometrics. A fascinating start to the day! #ISoP #Pharmacometrics #DrugDevelopment

Exciting to see invited Trainees showcasing their communication skills at #ACoP2024 during the Trainee Communication Challenge! They’re presenting their accepted abstracts to leading experts in the field of pharmacometrics. A fantastic opportunity to engage and learn from the best! #ISoP #ACoP2024 #Pharmacometrics #Communications

Monday morning kicked off with an inspiring President's Address by Vijay Ivaturi, highlighting ISoP's significant achievements this year and exciting plans for the future. Following that, Tawanda Gumbo delivered a thought-provoking State of the Art Lecture on "AI-Aided Virtual Disease Progression Clinical Trials – Merging Nonlinear Mathematical Modeling, Biology, and AI to Predict Individual Patient Responses in Global Health." A powerful start to an impactful week at ACoP2024! #ACoP2024 #ISoP #Pharmacometrics